PlaCCine Platform
Infectious Diseases (SARS-CoV-2 validation)
Key Facts
About IMUNON
IMUNON is focused on developing new medicines that harness the body's immune system using DNA-based technology. The company's core platforms, TheraPlas™ for immuno-oncology and PlaCCine for infectious disease vaccines, aim to generate potent, targeted immune responses. With a seasoned leadership team and a pipeline targeting significant unmet medical needs, IMUNON is advancing its clinical programs while exploring broader applications for its synthetic DNA delivery systems.
View full company profileAbout IMUNON
IMUNON is focused on developing new medicines that harness the body's immune system using DNA-based technology. The company's core platforms, TheraPlas™ for immuno-oncology and PlaCCine for infectious disease vaccines, aim to generate potent, targeted immune responses. With a seasoned leadership team and a pipeline targeting significant unmet medical needs, IMUNON is advancing its clinical programs while exploring broader applications for its synthetic DNA delivery systems.
View full company profile